John Paul Johnson - 01 Mar 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Mar 2024
Net transactions value
-$696,218
Form type
4
Filing time
05 Mar 2024, 19:09:42 UTC
Previous filing
26 Feb 2024
Next filing
26 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +12,123 +5.4% $0.000000 236,133 01 Mar 2024 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability $385,839 -11,213 -4.7% $34.41 224,920 01 Mar 2024 Direct F3, F4
transaction EVH Class A Common Stock Tax liability $310,378 -9,020 -4% $34.41 215,900 02 Mar 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.